More News
-
-
Fosun Tourism’s Businesses in China Deliver Outstanding Performance during New Year Holiday Seizes Momentum from Reopening and Leads Industry Recovery
2023-01-05(Hong Kong, 5 January 2023) – Fosun Tourism Group (“Fosun Tourism” or the “Group”, Hong Kong Stock Exchange Stock Code: 1992), a world-leading leisure-focused integrated tourism group, announced that during the 2023 New Year holiday period, the Group's core businesses in China, including Atlantis Sanya and Lijiang Foliday Town surpassed their
-
-
Guo Guangchang’s New Year’s Message: 2023 After the Rain Comes the Rainbow
2022-12-31Dear Fosuners,In just a few hours, the year 2022 will come to an end. I just visited the Yuyuan Garden to have a look at this year’s Lantern Festival. The team told me in advance that this year’s Lantern Festival has been upgraded in all aspects, but it still felt very surreal when I was on the Nine-turn Bridge.The history of the Yuyuan Garden Lantern Festival can be traced back
-
-
Fosun 2022 Recap: 10 Moments of the Year
2022-12-30The year has come to an end.Ten moments documented Fosun’s keywords of the year and witnessed the passing of our 2022.COMIRNATY® COVID-19 mRNA Vaccine. The self-paid vaccination service of the COMIRNATY® bivalent vaccine, which can protect against the Omicron variant, was rolled out in Hong Kong SAR and Macao SAR. Vaccination became available to German citizens living in the Chinese
-
-
Fosun International Garners Multiple ESG Awards in Domestic and International Markets
2022-12-30(30 December 2022) Recently, Fosun International received numerous accolades in domestic and international markets, including multiple ESG awards from international financial media International Business Magazine, Finance Derivative and Hong Kong stock connect information platform Zhitong Caijing.
-
-
BioNTech and Fosun Pharma Announce Full Regulatory Approval of their Mono- and Bivalent COVID-19 Vaccine COMIRNATY® in Individuals 12 Years and Older in Hong Kong
2022-12-23COMIRNATY® Original/Omicron BA.4/BA.5 is the first and currently only variant-adapted vaccine available for individuals 12 years and older which was granted a Biologics License Application equivalent in Hong KongIndividuals 12 years and older can now receive COMIRNATY® vaccines at medical institutions or clinics in Hong Kong with a medical prescription, in add